TETRAHYDROLIPSTATIN-CONTAINING COMPOSITIONS Russian patent published in 2001 - IPC

Abstract RU 2170579 C2

FIELD: medicine. SUBSTANCE: invention relates to compositions consisting of great number of particles with mean diameter about from 0.25 mm to 2 mm that can be used for treatment of patients with obesity. Particles have tetrahydrolipstatin, stabilizing agent of its hydrolytic decomposition and at least one pharmaceutically acceptable excipient, not less. Stabilizing agent shows greater rate of moisture absorption as compared with that for tetrahydrolipstatin. Particles can be made as granules or micropills. Stabilizing agent is taken among the group: polyvinylpyrrolidone, lactose, their mixture, hydroxy- -methylcellulose and hydroxypropylcellulose. Particles can be used for preparing standard dosed form, for example, tablets and capsules. Particles of composition do not show ability to stick or loosen up and tetrahydrolipstatin in their composition shows good stability. EFFECT: improved properties of compositions. 15 cl, 4 tbl, 6 ex

Similar patents RU2170579C2

Title Year Author Number
APPLICATION OF INHIBITORS OF GASTRO- INTESTINAL LIPASE 1998
  • Khoptman Dzhonatan Brajan
RU2201272C2
PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR 2010
  • Aleksander Glomme
  • Paul' Vojtera
RU2537224C2
DIPHOSPHONIC ACID-CONTAINING COMPOSITIONS 1999
  • Gabel' Rol'F-Diter
  • Prajz Val'Ter
  • Voog Genrikh
RU2207860C2
PHARMACEUTICAL COMPOSITIONS CONTAINING PRODRUG OF HCV POLYMERASE INHIBITOR 2010
  • Chatterdzhi Ashish
  • Desaj Dipen
  • Sandkhu Kharprit K.
  • Shakh Navnit Khargovindas
RU2489153C2
NOVEL PHARMACEUTICAL COMPOSITION 2001
  • Barb'E P'Er
  • Advari Pol'
  • Lengsfel'D Khans
RU2241462C2
PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN 2003
  • Bajlli Zhak
  • Martin Rajner Ojgen
  • Rab Zuzanna
RU2297221C2
NEW PYRROLOCARBAZOLES 1995
  • Kris Allen Broka
RU2162089C2
PHARMACEUTICAL COMPOSITION 1995
  • Vantanee Fuapradit
  • Aruna Rejlkar
  • Navnit Khargovindas Shakh
RU2138251C1
COMPOSITION WITH HIGH DOSE OF IBANDRONAT 2003
  • Kehstle Khans-G.
  • Mejer Bernar
RU2315603C2
PHARMACEUTICAL PREPARATION 1994
  • Zhan-Pol' Klozel'
  • Martin Klozel'
  • Vol'Fgang Osterrider
RU2146522C1

RU 2 170 579 C2

Authors

Navnit Khargovindaz Shakh

Maks Tseller

Dates

2001-07-20Published

1998-01-24Filed